Research Team
Cameron Joyce, MPA
Contact
Focus Areas
Degrees
B.A. in Political Science, University of North Carolina at Charlotte
Master of Public Administration, University of North Carolina at Charlotte
Cameron Joyce is a Senior Policy Analyst at the Duke-Margolis Institute for Health Policy.
Cameron contributes to the Institute’s Biomedical Innovation and Evidence Development portfolio, focusing on digital health, AI governance, and drug supply chain resilience. His work spans advanced manufacturing, drug shortage mitigation, and policy research on antimicrobial resistance (AMR). Additionally, he has extensive experience collaborating with the FDA to strengthen regulatory science and streamline the development of safe, effective medical products.
Comment Letter
Duke-Margolis Drug Shortages Request for Information Comment Letter
Stephen Colvill, Marianne Hamilton Lopez, Gerrit Hamre, Cameron Joyce, Thomas Roades
2023
Read MoreWhite Paper
Advancing Federal Coordination to Address Drug Shortages
Stephen Colvill, Thomas Roades, Gerrit Hamre, Marianne Hamilton Lopez, Cameron Joyce, Remi Shendell, Mark McClellan
2023
Read MoreIssue Brief
Considerations for FDA’s New Advanced Pharmaceutical Manufacturing Programs
Stephen Colvill, Cameron Joyce, Thomas Roades, Gerrit Hamre
2024
Read MoreWhite Paper
Enhancing Representative Enrollment through Point-of-Care Trials
Valerie J. Parker, Cameron Joyce, Sandra E. Yankah, Trevan Locke, Marianne Hamilton Lopez
2024
Read MoreWhite Paper
Fostering Collaboration to Advance Shared Goals for Representativeness in Clinical Trials
Sandra E. Yankah, Valerie J. Parker, Cameron Joyce, Trevan Locke, Andrea Thoumi, Marianne Hamilton Lopez
2024
Read MoreWhite Paper
Building a Resilient and Secure Pharmaceutical Supply Chain: The Role of Geographic Diversification
Thomas Roades, Cameron Joyce, Madi Cordle, Katherine Hamilton, Gerrit Hamre, Mark McClellan
2024
Read MoreIssue Brief
Leveraging Diagnostic Stewardship to Advance Appropriate Diagnostic Use
Cameron Joyce, Nicholas Harrison
2024
Read MoreComment Letter
Duke-Margolis Comments and Recommendations to House Ways and Means Committee Regarding Chronic Drug Shortages
Stephen Colvill, Thomas Roades, Gerrit Hamre, Cameron Joyce, Mark McClellan
2024
Read MoreComment Letter
Drug Shortage Prevention and Mitigation Act - Comment Letter
Stephen Colvill, Thomas Roades, Cameron Joyce, Gerrit Hamre, Mark McClellan
2024
Read More